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Abstract
Parachlamydia acanthamoebae is a Chlamydia-like organism that easily grows within Acanthamoeba spp. Thus, it probably uses these wide-
spread free-living amoebae as a replicative niche, a cosmopolite aquatic reservoir and a vector. A potential role of P. acanthamoebae as
an agent of lower respiratory tract infection was initially suggested by its isolation within an Acanthamoeba sp. recovered from the water
of a humidiﬁer during the investigation of an outbreak of fever. Additional serological and molecular-based investigations further sup-
ported its pathogenic role, mainly in bronchiolitis, bronchitis, aspiration pneumonia and community-acquired pneumonia.
P. acanthamoebae was shown to survive and replicate within human macrophages, lung ﬁbroblasts and pneumocytes. Moreover, this strict
intracellular bacterium also causes severe pneumonia in experimentally infected mice, thus fulﬁlling the third and fourth Koch criteria for
a pathogenic role. Consequently, new tools have been developed for the diagnosis of parachlamydial infections. It will be important to
routinely search for this emerging agent of pneumonia, as P. acanthamoebae is apparently resistant to quinolones, which are antibiotics
often used for the empirical treatment of atypical pneumonia. Other Chlamydia-related bacteria, including Protochlamydia naegleriophila,
Simkania negevensis and Waddlia chondrophila, might also cause lung infections. Moreover, several additional novel chlamydiae, e.g. Cribla-
mydia sequanensis and Rhabdochlamydia crassiﬁcans, have been discovered and are now being investigated for their human pathogenicity.
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Introduction
Identiﬁcation of the aetiological agent of pneumonia is
important for the selection of appropriate antibiotic therapy.
However, current diagnostic approaches fail to identify a
causative agent in approximately 50% of cases, thereby
demonstrating that still unknown agents of pneumonia
remain to be identiﬁed.
Our research focuses on strict intracellular bacteria, as they
are not identiﬁed by routine culture and may thus represent
yet unidentiﬁed agents of pneumonia. New bacterial species
are sought, and their role in lower respiratory tract infections
is investigated by developing diagnostic tools that will be
applied to patients with and without pneumonia by determin-
ing the replicative permissiveness of macrophages, pneumo-
cytes and lung ﬁbroblasts with respect to these obligate
intracellular bacteria, and by studying the pathogenesis of
selected putative agents of pneumonia in a mouse model
(Fig. 1). This overall strategy was applied to determine the role
of Parachlamydia acanthamoebae (a Chlamydia-like organism
living in amoebae) and of other novel chlamydiae as potential
agents of lower respiratory tract infections in humans. Using
established diagnostic tools, the role of these obligate intra-
cellular bacteria is currently being investigated also in other
clinical settings. A further goal is to better understand the
evolution and virulence determinants of these novel chlamy-
diae and to deﬁne their zoonotic risk (Fig. 1).
Although research on these new chlamydiae is impaired by
the absence of a genetic system and by the difﬁculty of obtain-
ing large amounts of puriﬁed bacteria, much information has
been obtained during the last decade by the different groups
working in this ﬁeld. Here, the current knowledge concerning
the biology of P. acanthamoebae is summarized, and its patho-
genicity regarding humans and animals is discussed.
Biology of P. acanthamoebae
Deﬁnitions, biodiversity and taxonomy
‘Novel chlamydiae’, ‘amoebae-resisting bacteria’, ‘Chlamydia-
like organisms’ and ‘Chlamydia-related bacteria’ are various
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terms used to refer to a large variety of strict intracellular
bacteria belonging to the Chlamydiales order, but exhibiting
sufﬁcient biological differences to be assigned to families
other than the Chlamydiaceae.
The biodiversity of these Chlamydia-related bacteria, as
evidenced by both molecular-based studies [1–3] and cul-
ture-based studies [4–6], led to the proposal of several new
families, genera, species and Candidatus species (Table 1)
[4,7–14].
Phenotypic investigation of new chlamydial species is
mainly based on comparison of their growth rates in var-
ious cell lines, including different amoebal species, and on
speciﬁc traits observed using electron microscopy. For
example, elementary bodies of members of the Rhabdochla-
mydiaceae family are ovoid and exhibit a ﬁve-layered cell
wall [11,14], whereas members of the Criblamydiaceae
family exhibit typical star-like elementary bodies [4,6]
(Fig. 1).
Serotyping may be used to infer phyletic relationships, as
serological cross-reactivity is high among members of the
same species [12,15]. The serological differentiation index is
measured by comparing the antibody reactivity of autologous
and heterologous mouse sera with each novel Chlamydia sp.
available in culture [15].
Given the workload required to grow and purify the large
amount of chlamydiae needed for DNA–DNA hybridization
studies, genotypic analyses are mainly based on the
sequences of a few numbers of genes, e.g. the 16S rRNA
and 23S rRNA genes [4,7,8]. For these two ribosomal genes,
cut-off values of 80%, 90% and 95% have been proposed to
FIG. 1. Schema of research programme aimed at discovering new bacterial species and further studying them to determine their role in lower
respiratory tract infections, by developing different diagnostic tools to study patients with and without pneumonia, by determining the permis-
siveness of macrophages, pneumocytes and lung ﬁbroblasts with respect to these obligate intracellular bacteria, and by studying the pathogenic
properties of selected putative agents of pneumonia in a mouse model. Several new species have been discovered recently, including two mem-
bers of the Criblamydiaceae family: Criblamydia sequanensis and Estrella lausannensis. The availability of these new bacterial species allows the pro-
duction and puriﬁcation of antigens useful for developing serological assays. Antigens are also used to immunize mice and rabbits to obtain
polyclonal antibodies needed for cell biology, for immunohistochemistry, and as controls for serology. Diagnostic tools speciﬁcally developed
include immunoﬂuorescence, western blot, ELISA, PCR, immunohistochemistry and amoebal co-culture.
CMI Greub Parachlamydia and pneumonia 19
ª2009 The Author
Journal Compilation ª2009 European Society of Clinical Microbiology and Infectious Diseases, CMI, 15, 18–28
assign a given species at the order, family and genus level,
respectively [7] (Fig. 2). To deﬁne new species, a limit of
97% might be considered. However, these cut-off values
should be used cautiously, and the proposal of a new species
should also rely on phenotypic and phylogenetic analyses.
Congruent results with a minimum of ﬁve different phylogen-
etically informative genes are generally required [16]. In the
near future, the availability of full genome sequences of sev-
eral novel chlamydiae will contribute to improving chlamydial
taxonomy.
Interactions with free-living amoebae
P. acanthamoebae strains were ﬁrst identiﬁed within Acantha-
moeba amoebae isolated from the nasal mucosa of healthy
volunteers [17,18]. The role of these free-living amoebae as
a widespread aquatic reservoir was thus suspected early on.
By analogy with Legionella, P. acanthamoebae may have
used amoebae as an evolutionary crib to select virulence
traits [19], explaining its adaptation for survival within
macrophages (Table 2). Moreover, amoebae have probably
played a pivotal role in the exchange of genes between the
Rickettsiales and Chlamydiales (Table 2), as suggested by the
occurrence of a similar tra operon in both clades [20,21]
(see below).
The life cycle of P. acanthamoebae in Acanthamoeba has
been thoroughly studied, and it has been shown that Para-
chlamydia elementary bodies generally enter passively, via
phagocytosis, before differentiating into reticulate bodies that
may divide by binary ﬁssion, before redifferentiating into ele-
mentary bodies [22] (Fig. 3). Bacteria are then released from
amoebae within expelled vesicles or after amoebal lysis [22].
Crescent-shaped bodies of P. acanthamoebae (Fig. 3), another
infectious stage, may be observed: (i) outside of the amoe-
bae, during the process of being internalized by phagocytosis;
or (ii) late in the intra-amoebal cycle, at a time when the
amoeba is mainly ﬁlled with elementary bodies [22]. These
crescent-shaped bodies have also been observed among
other members of the Parachlamydiaceae, among the Waddlia-
ceae, and to a lesser extent among the Criblamydiaceae and
FIG. 2. 16S rRNA gene sequence divergence among different
members of the Chlamydiales and the use of this ribosomal gene to
classify a new strain at the family and genus levels, using cut-offs
proposed by Everett et al. [7].
TABLE 1. Family, genus and species biodiversity within the
order Chlamydiales
Bacterial namea References
Chlamydiaceaeb
Chlamydia trachomatis [7]
Chlamydophila pneumoniae [7]
Clavochlamydia salmonis [58]
Criblamydiaceae
Criblamydia sequanensis [4]
Parachlamydiaceae
Neochlamydia hartmanellae [8]
Parachlamydia acanthamoebae [18]
Protochlamydia amoebophila [10]
Protochlamydia naegleriophila [12]
Piscichlamydiaceae
Piscichlamydia salmonis [9]
Rhabdochlamydiaceae
Rhabdochlamydia crassiﬁcans [11]
Rhabdochlamydia porcellionis [14]
Simkaniaceae
Fritschea bemisiae [13]
Fritschea eriococci [13]
Simkania negevensis [59]
Waddliaceae
Waddlia chondrophila [7]
Waddlia malaysiensis [60]
aClassiﬁed by family-level lineage, in alphabetical order; any new species-level
lineages are reported, including Candidatus spp. such as Protochlamydia neaglerio-
phila, Rhabdochlamydia crassiﬁcans and Piscichlamydia salmonis.
bOnly a few of the Chlamydiaceae are listed.
TABLE 2. Role of amoebae for amoebae-resisting members
of the Chlamydiales
Role of amoebae References
Widespread reservoir [1,6,35,61]
Replicative niche [1,19,61,62]
‘Trojan horse’ [19,35,63]
‘Protective armour’a [19,62]
‘Training ground’ to select virulence traits [19,64]
‘Evolutionary crib’ in which to adapt to macrophages [19,42,65]
Gene exchange between amoebal symbionts/pathogens [20,21]
Tool with which to recover new amoebae-resisting
members of the Chlamydiales
[4,6,19,66]
aEspecially important for species such as Waddlia chondrophila, which may be
present in large numbers within amoebal cysts; of note, Parachlamydia acantha-
moebae prevents encystment and is not found in mature cysts [22].
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Simkaniaceae. A particular composition of the cell membrane
of these novel chlamydiae probably explains this special cell
morphology, which might account for a speciﬁc reaction to
ﬁxatives used for sample preparation prior to confocal and
electron microscopy.
Insights into the evolution of the Parachlamydiaceae
The common ancestors of the Parachlamydiaceae and Chlamy-
diaceae already possessed an energy parasitism-encoding gene
more than one billion years ago [23]. Thus, an ancestral form
of the Chlamydiae was already parasitizing eukaryotes when
protists, plants and animals diverged. Amoebae-resisting chla-
mydiae have thus co-evolved, over a period of more than
one billion years, alongside their amoebal host, progressively
acquiring virulence traits that enable them to resist killing by
macrophages, whereas the Chlamydiaceae progressively
adapted to speciﬁc animal species. Since their divergence
from the Chlamydiaceae (which occurred ‡0.7 billion years
[23,24]), the Parachlamydiaceae have apparently been less
prone to genome reduction than the Chlamydiaceae, as they
exhibit genome sizes two to three times larger than the
Chlamydiaceae. This larger genome size may partially be due
to: (i) gene duplication, as suggested by the occurrence of
numerous genes containing leucine-rich repeats in the
genome of P. amoebophila [25]; and (ii) gene acquisition, as
supported by the presence in the genome of P. amoebophila
of a large number of plant-like genes [24] and of Pam100G, a
large genomic island of proteobacterial origin [21].
This genomic island identiﬁed in the genome of
P. amoebophila was shown to contain: (i) several genes
involved in gene mobility and DNA metabolism, which are
characteristic of genomic islands; and (ii) a tra operon encod-
ing a type 4 secretion system (T4SS), which is probably
involved in conjugative DNA transfer [21]. Interestingly, a
similar tra operon was also found on a plasmid of Simkania
negevensis (G. Myers, personal communication) and of several
rickettsiae [20,26], further suggesting a role of this T4SS in
conjugative DNA transfer. Whether this T4SS, which is
absent in the Chlamydiaceae, is also involved in protein trans-
fer remains to be demonstrated. P. amoebophila was also
found to present a unique electron carrier that allows
exchange of NAD+ against ADP [27].
Thus, the Parachlamydiaceae do not merit the label ‘Chla-
mydia-like’, as they differ greatly from the Chlamydiaceae (see
above and Table 3).
Virulence genes identiﬁed in the genome of Protochlamydia
amoebophila
Few putative virulence factors have been identiﬁed to date.
As the genome of P. acanthamoebae is not yet available,
(a)
(d)(c)
(b)
FIG. 3. (a) Confocal microscopy showing Par-
achlamydia acanthamoebae strain Hall’s coccus
within Acanthamoeba castellanii. The cell wall
of P. acanthamoebae (in green) was stained
with polyclonal mouse anti-Parachlamydia anti-
bodies, whereas its DNA was stained with
4¢,6-diamidino-2-phenylindole (DAPI). The
amoeba was stained with concavalin A. 1000·
magniﬁcation. (b) Electron microscopy show-
ing Acanthamoeba polyphaga infected by
P. acanthamoebae. Elementary bodies (arrow-
head) and reticulate bodies (arrow) can be
seen within the inclusions. N, amoebal nucleus.
3500· magniﬁcation. (c) Elementary body of
P. acanthamoebae as viewed by electron micro-
scopy. 70 000· magniﬁcation. (d) Crescent-
shaped body of P. acanthamoebae as viewed by
electron microscopy. 70 000· magniﬁcation.
CMI Greub Parachlamydia and pneumonia 21
ª2009 The Author
Journal Compilation ª2009 European Society of Clinical Microbiology and Infectious Diseases, CMI, 15, 18–28
this has mainly been achieved by comparative genomics,
based on the genome of Protochlamydia amoebophila [24]
and deduction from current knowledge concerning the
Chlamydiaceae. Protochlamydia amoebophila possesses a gene
homologous to that encoding chlamydial protease-like activ-
ity factor, a secreted protein that degrades human tran-
scription factors important for expression of both class I
and class II major histocompatibility complexes [28]. More-
over, chlamydial protease-like activity factor has been
shown to degrade keratin, thereby potentially playing a role
in the local expansion of inclusions [29]. OmcB, a cysteine-
rich outer membrane protein crucial for adhesion of chla-
mydiaceae to endothelial and epithelial cells [30], is also
encoded in the genome of Protochlamydia amoebophila.
Moreover, in the genome of Protochlamydia amoebophila,
and in the genomes of other amoebae-resisting chlamydiae
of unﬁnished sequence status, several genes encoding a
type 3 secretion system have been identiﬁed [24,31], sug-
gesting that this important chlamydial virulence factor may
also play a role in the pathogenicity of Chlamydia-related
bacteria. However, several virulence factors of the Chlamy-
diaceae are absent from the genome of Protochlamydia
amoebophila (Table 4). The future availability of the gen-
omes of S. negevensis, P. acanthamoebae, Protochlamydia nae-
gleriophila and Waddlia chondrophila will contribute to
determining the distribution of identiﬁed virulence genes
among these different lineages.
Medical Importance of P. acanthamoebae
Clinical studies
The prevalence of human lung infections due to Parachlamydia
is currently unknown. It may well be underestimated, as these
fastidious intracellular bacteria can only be cultivated from
clinical samples using amoebal culture, a procedure not routi-
nely performed in diagnostic laboratories. Human exposure
to these Parachlamydiaceae is likely as shown by the ampliﬁca-
tion of parachlamydial DNA from nose and/or throat swabs
[32–34] and recovery of two Parachlamydia strains from
amoebae isolated from the nasal mucosa [17,18].
More importantly, there are several lines of evidence sup-
porting the medical importance of P. acanthamoebae (Table 4;
reviewed in [35,36]). The ﬁrst hint was the identiﬁcation of
the P. acanthamoebae strain Hall’s coccus within an amoeba
isolated from the water of a humidiﬁer linked to an outbreak
of fever [37]. This humidiﬁer was investigated only for the
presence of amoebae, given the high attack rate observed and
given the recognized role of amoebae in the epidemiology of
Legionella, whose pathogenic role was also initially documen-
ted in a similar fashion during the original outbreak in 1976.
Several serological studies have suggested a role for
P. acanthamoebae in community-acquired pneumonia. In one of
these studies, eight (2.2%) of 371 patients with community-
acquired pneumonia exhibited positive Parachlamydia serology,
TABLE 3. Differences and similarities between the Parachlamydiaceaea and Chlamydiaceae (adapted from [21,24,67])
Parachlamydiaceae Chlamydiaceae Referencesb
Developmental stages Elementary bodies, reticulate
bodies and crescent bodies
Elementary bodies and reticulate
bodies
[22]
Growth within free-living amoebae ++++ ± [8,50]
Growth within human macrophages + + [42,44]
Effect on apoptosis Induce macrophage apoptosis Prevent apoptosis [42]
Effect on cytokine production No production of proinﬂammatory
cytokines
Production of proinﬂammatory
cytokines
[45]
Characteristics of the replicative vacuole Endocytic pathway (phagosome) Exocytic pathway (Golgi) [44]
Genome size c. 2.4–3 Mbp c. 1–1.3 Mbp [24]
GC content 35–36% 39–41% [24]
Type 3 secretion system Present Present [24,31]
Type 4 secretion system Present Absent [24]
Putative conjugative DNA transfer system Present Absent [21]
Leucine-rich repeat proteins Present Absent [25]
Chlamydial protease-like activity factor Present Present [24]
OmcB Present Present [24]
OmpA Absent Present [24]
Polymorphic outer membrane proteins Absent Present [24]
Inc protein(s) Present Present [24]
Chlamydial protein associated with death domain Absent Present [24]
ATP/ADP translocase Present Present [23,68]
Electron carrier (NAD/ADP-transporter) Present Absent [27]
Susceptibility to quinolones Resistant Susceptible [49,55]
Susceptibility to macrolides Susceptible Susceptible [49]
aLargely deduced from studies on Parachlamydia acanthamoebae and from genome sequencing of Protochlamydia amoebophila; some characteristics, e.g. replication in human
macrophages, may only be characteristic of P. acanthamoebae and not of all other members of the Parachlamydiaceae; similarly, the presence of an NAD/ADP-transporter has
been demonstrated only for Protochlamydia amoebophila.
bReferences for the Chlamydiaceae are not systematically provided.
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as compared to none of 511 healthy controls (p <0.01) [38]. In
this study, two patients presented serological evidence of
acute parachlamydial infection: a 68-year-old renal transplant
recipient and a 21-year-old man with adult-onset Kawasaki dis-
ease [38]. A possible role of Parachlamydia in aspiration pneu-
monia was also determined. Indeed, while patients hospitalized
on a neurosurgical ward were being investigated for a possible
association of P. acanthamoebae infection with nosocomial
infection, three seroconversions, which all occurred in patients
with aspiration pneumonia, were unexpectedly identiﬁed [39].
The identiﬁcation of 16S rRNA gene sequences of Para-
chlamydiaceae from bronchoalveolar lavage ﬂuid and sputum
are additional indications of a pathogenic role of
P. acanthamoebae in lower respiratory tract infections [32–
34,40]. It is of note that one of the lower respiratory tract
samples from which P. acanthamoebae DNA was ampliﬁed
was taken from a human imunodeﬁciency virus-infected sub-
ject with low CD4 lymphocyte counts [40]. Parachlamydial
DNA was also ampliﬁed from monocytes taken from a
patient with bronchitis [32]. Finally, P. acanthamoebae was
ampliﬁed from nasopharyngeal swabs taken from children
suffering from bronchiolitis of unexplained aetiology [41].
In summary, a possible role is emerging for Parachlamydia
as an agent of bronchitis, bronchiolitis, community-acquired
pneumonia and aspiration pneumonia.
In vitro studies
To further evaluate the pathogenic role of P. acanthamoebae,
its ability to enter into human macrophages was investigated.
This strict intracellular bacterium was able to enter and
replicate within human monocyte-derived macrophages [42],
representing a good example of the adaptation of an amoe-
bae-resisting Chlamydiae to macrophages. However, unlike
the Chlamydiaceae, which mainly survive within the target
cells by relocalizing in vacuoles associated with the exocytic
pathway [43], P. acanthamoebae bacteria were able to survive
within endocytic acidic vacuoles, by preventing the acquisi-
tion of cathepsin, a lysosomal hydrolase [44]. Moreover,
P. acanthamoebae did not induce signiﬁcant cytokine produc-
tion; that is, it remained partially unrecognized by human
macrophages [45]. However, parachlamydial macrophage
infection was only partially successful, as this strict intracellu-
lar bacterium replicated only to a low extent and induced
the apoptosis of the macrophage [42], thereby preventing its
use as a replicative niche.
The permissiveness of lung ﬁbroblasts and pneumocytes,
and the absence of a cytopathic effect on these cells, were
consequently of importance, as these lung cells may allow
sustained parachlamydial viability for prolonged periods [46].
On the basis of these in vitro studies, it was hypothesized
that: (i) P. acanthamoebae escapes innate immune defenses by
inducing macrophage apoptosis, and via an unknown mechan-
ism preventing cytokine release by these pivotal phagocytic
cells; (ii) P. acanthamoebae may disseminate to other organs
when internalized in monocytes; and (iii) P. acanthamoebae
may cause lung infection by replicating within pneumocytes.
Animal models of pneumonia
The aetiological role of P. acanthamoebae in human pneumo-
nia, based on clinical observations and in vitro studies, has
TABLE 4. Main clinical studies supporting the human pathogenicity of Parachlamydia acanthamoebae and of other Chlamydia-
related bacteria
Bacterial species Disease/condition Evidence based on: References
Lower respiratory tract infections
Parachlamydia acanthamoebae Community-acquired pneumonia Immunoﬂuorescence, PCR + sequencing [37,38] [33,34,40]
Aspiration pneumonia Immunoﬂuorescence, western blot [39]
Bronchitisa PCR + sequencing [32]
Bronchiolitis Real-time PCR [41]
Simkania negevensisb Bronchiolitis PCR, ELISA, culture [69]
Pneumonia in children Immunoﬂuorescence [70,71]
Pneumonia in adults ELISA [72]
Exacerbation of chronic obstructive
lung diseases
ELISA [73]
Protochlamydia naegleriophila Community-acquired pneumoniac Direct immunoﬂuorescence, speciﬁc
real-time PCR, and PCR + sequencing
[12]
Protochlamydia amoebophila Community-acquired pneumoniac PCR + sequencing [74]
Waddlia chondrophila Community-acquired pneumoniac PCR + sequencing [74]
Rhabdochlamydia porcellionis Community-acquired pneumoniac PCR + sequencing [74]
Other human diseases
Parachlamydia acanthamoebae Arteriosclerosisa PCR + sequencing, serology [39,54]
Miscarriagea Immunoﬂuorescence, western blot [52,53]
Multiple sclerosisa PCR [75]
Waddlia chondrophila Miscarriage Immunoﬂuorescence, western blot [52,53]
aOnly weak evidence is available.
bThe role of Simkania negevensis in lower respiratory tract infection remains controversial, as studies by Kumar et al. [76] and Johnsen et al. [77] did not ﬁnd any correlation
between S. negevensis and lower respiratory tract infections; see also the review by Friedman et al. on S. negevensis [78].
cOnly one case reported.
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been further supported by mouse models of pneumonia
[47,48] (Fig. S1). Thus, Balb-C mice inoculated intratracheally
with 2.5 · 108 bacteria lost c. 20% of their body weight in
48 h, concomitant with the development of severe pneumo-
nia [47]. In the absence of therapy, mortality due to the
P. acanthamoebae pneumonia was 80% after 6 days. More-
over, pneumonia was also observed after intranasal adminis-
tration of a similar inoculum [48]. In both models,
pneumonia was initially purulent, with a predominantly neu-
trophilic alveolar inﬁltrate, which later contained mainly
macrophages (Fig. S1). It is of note that infection of both
macrophages and pneumocytes could be documented in vivo.
These results demonstrate that P. acanthamoebae may cause
severe pneumonia in experimentally infected mice, thus ful-
ﬁlling the third and fourth Koch criteria for a pathogenic role
of this intracellular bacterium. These mouse models are now
used: (i) to better determine which cell types are infected;
(ii) to deﬁne the innate immune determinants of
P. acanthamoebae recognition; (iii) to investigate the impact
of immunosuppression on the course of parachlamydial infec-
tion; and (iv) to determine in vivo the antibiotic susceptibility
of P. acanthamoebae.
Diagnosis of parachlamydial infections
The diagnostic approach to infections due to
P. acanthamoebae has recently been reviewed [36].
Molecular approaches. Molecular approaches probably con-
stitute the reference standard for investigation of patients
with possible P. acanthamoebae infection. Parachlamydia real-
time PCRs that target the 16S rRNA-encoding [41] and the
ADP/ATP-translocase-encoding genes are used [40]. Both
PCRs exhibit good sensitivity (£10 copies/lL) and speciﬁcity
at the genus level [40,41]. Moreover, samples that are posi-
tive according to both PCRs are unlikely to be false-positive
due to contamination. Samples that are strongly positive
(>500 copies/lL) may be further investigated by PCR and
sequencing of a large 1400-bp fragment of the 16S rRNA-
encoding gene (see Table 5 for primers), allowing precise
genetic and phylogenetic studies.
Serology. Serology is another useful diagnostic methodology.
Immunoﬂuorescence using puriﬁed elementary bodies has
been mainly used [38,39]. Antibody titres of ‡1/64 and 1/32
have been considered as cut-offs for IgG and IgM positivity,
respectively [36]. This parachlamydial serology appeared to
be highly speciﬁc, exhibiting no cross-reactivity, or marginal
cross-reactivity, with Chlamydia trachomatis, Chlamydophila
pneumoniae, W. chondrophila, S. negevensis and Criblamydia
sequanensis [15]. The documented cross-reactivity between
P. acanthamoebae and Protochlamydia spp. [12,15], however,
calls for caution when interpreting a positive immunoﬂuores-
cence result. Western blot may be used to conﬁrm positive
results [15,39]. In the future, the availability of the genome
of P. acanthamoebae will allow proteomic studies to identify
immunogenic proteins to be used in an ELISA.
Cell culture. Current cell culture protocols have been
unsuccessful in recovering any parachlamydial strains from
human samples, including samples from which parachlamydial
DNA was ampliﬁed. This is probably because eukaryotic cell
lines such as Vero, McCoy and HeLa cells do not allow the
replication of P. acanthamoebae [49]. Other cells, such as
A549 pneumocytes and lung ﬁbroblasts, do not appear to
offer a better means of isolating parachlamydial strains in cul-
ture, as replication was relatively limited [46]. Given the rapid
and logarithmic multiplication of P. acanthamoebae in amoebae
[50], amoebal co-culture is a promising tool. Amoebal co-cul-
ture is a cell culture system using amoebae as cells. Bacterial
growth is suspected in the presence of amoebal lysis (Fig. S2).
It has the advantage over conventional cell culture of being
applicable to lower respiratory tract samples that are fre-
quently contaminated with endogenous pharyngeal ﬂora. The
efﬁciency of amoebal co-culture may be further improved by
spinoculation (a centrifugation-based inoculation).
A two-step approach, i.e. amoebal enrichment on non-
nutritive agar seeded with Escherichia coli, followed by an
investigation of the recovered amoebae for a chlamydial sym-
biont, is another method that has been used to isolate Para-
chlamydia from clinical samples. However, this approach, by
which P. acanthamoebae has successfully been isolated from
the nasal mucosa of healthy volunteers [18], appeared to be
less effective than amoebal co-culture for the recovery of
Chlamydia-related bacteria from environmental samples [6].
TABLE 5. Primers and probes recommended for molecular
diagnosis of Parachlamydia acanthamoebae infections
Target gene, primers/probes References
ATP/ADP-translocase-encoding gene (tlc), real-time TaqMan PCR [40]
Adp81F, 5¢-TAG TGA TCT GCT ACG GGA TTT-3¢
Adp84R, 5¢-TTG GAT TAG GAT ATT GCT TAA A-3¢
AdpSa, 6-FAM-5¢-AAC CTT GTA GAA GTA ACC
CTG GAA GAA CCA GC-3¢-BHQ
16S rRNA-encoding gene, real-time TaqMan PCR [41]
PacF, 5¢-CTC AAC TCC AGA ACA GCA TTT-3¢
PacR, 5¢-CTC AGC GTC AGG AAT AAG C-3¢
PacSa, 6-FAM-5¢-TTC CAC ATG TAG CGG TGA
AAT GCG TAG ATA TG-3¢-BHQ
16S rRNA-encoding gene, PCR and sequencing [4,7]
16SigF, 5¢-CGG CGT GGA TGA GGC AT-3¢
Rp2chlam, 5¢-CTA CCT TGT TAC GAC TTC AT-3¢
aTaqMan probes, different reporters and quenchers may be used without signiﬁcant
differences in sensitivity; however, black hole quencher 1 (BHQ-1) as quencher and
tetrachloro-6-carboxyﬂuorescein (FAM) as reporter are recommended.
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Immunohistochemistry. Immunohistochemistry will be pivotal
in documenting the presence of P. acanthamoebae within
infected tissues, and hence, in deﬁnitively demonstrating the
role of P. acanthamoebae in pneumonia. Using polyclonal
anti-Parachlamydia antibodies obtained by immunizing rabbits
with puriﬁed elementary bodies, immunohistochemistry pro-
tocols have been developed. These tools have, so far, been
applied mainly to samples taken from bovines [51] and
from experimentally infected mice [47]. Like immunoﬂuor-
escence, immunohistochemistry proved to be speciﬁc, with
marginal cross-reactivity with other members of the Chlamy-
diales [51]. As lung biopsy specimens are infrequently
obtained from patients with atypical pneumonia, only a lim-
ited number of lung samples have been investigated for the
presence of P. acanthamoebae, and the results have been
uniformly negative (G. Greub, unpublished data). In the
future, it will be important to obtain monoclonal anti-Para-
chlamydia antibodies to allow wider use of immunohisto-
chemistry.
Other infections due to P. acanthamoebae
The tools developed to determine the role of
P. acanthamoebae in lower respiratory tract infections were
also used to study other clinical entities. This allowed the
identiﬁcation of a possible role of P. acanthamoebae in mis-
carriage: seven (2.6%) of 269 women who miscarried exhib-
ited anti-Parachlamydia antibodies, as compared to none of
169 women who did not miscarry (p <0.05) [52,53]. The
role of Parachlamydia in atherosclerosis, uveitis and urogen-
ital infection is currently being investigated, as 16S rRNA
gene sequences related to Parachlamydia have been ampliﬁed
from arterial, aqueous humor and cervical samples [32,54].
Treatment of infections due to P. acanthamoebae
The antibiotic susceptibility of two strains of
P. acanthamoebae has been studied in vitro by amoebal co-cul-
ture. Their susceptibility to macrolides, tetracyclines and
rifampin, and their resistance to quinolones, has been
demonstrated [49]. This unexpected resistance to quinolones
might be explained by substitutions at positions 83 and 70 of
the GyrA quinolone resistance-determining region [55]. Con-
sequently, in the absence of data from animal models and
data from case reports, azithromycin, clarithromycin and/or
doxycycline might be used therapeutically.
Zoonotic risk
Although water and free-living amoebae have been largely
considered to be the source of human infections due to
P. acanthamoebae, the zoonotic risk associated with infection
in ruminants should be assessed, both in pneumonia and as
causative agents of pregnancy loss of unknown aetiology.
Indeed, the abortigenic role of P. acanthamoebae has been
recently highlighted in bovines, by demonstrating the pre-
sence of P. acanthamoebae in bovine placenta by PCR, immu-
nohistochemistry and electron microscopy [51]. Moreover,
abortion in sheep and goats has also been linked to infection
with P. acanthamoebae [56]. In addition, pets should be con-
sidered as possible sources of infection, as both guinea pigs
and cats may be infected and/or colonized with
P. acanthamoebae [57,58].
Conclusions
In conclusion, P. acanthamoebae probably represents a new
agent of lower respiratory tract infection, which may cause
bronchitis, bronchiolitis, community-acquired pneumonia and
aspiration pneumonia. Deﬁnite proof of its role in these con-
ditions is, however, not yet available, and will depend on
demonstrating the presence of bacteria in the diseased lung
by immunohistochemistry and culture. Diagnostic tools
developed during the last decade will contribute to an under-
standing of its epidemiology and its pathogenic role in pneu-
monia and other clinical contexts. The future availability of
its genome will further contribute to an understanding of the
biology of this emerging pathogen and will prove useful in
developing new diagnostic approaches.
Other Chlamydia-related bacteria, e.g. S. negevensis, Proto-
chlamydia naegleriophila, Protochlamydia amoebophila,
W. chondrophila and Rhabdochlamydia porcellionis, might also
cause lower respiratory tract infections (Table 4). Moreover,
W. chondrophila might play a role in miscarriage. Finally, sev-
eral additional novel chlamydiae, e.g. Criblamydia sequanensis
and Rhabdochlamydia crassiﬁcans, have been discovered and
are now being investigated for human pathogenicity.
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